Back to Journals » OncoTargets and Therapy » Volume 10

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Total article views   HTML views PDF downloads Totals
10,895 Dovepress* 9,268+ 1,303 10,571
PubMed Central* 1,627 279 1,906
Totals 10,895 1,582 12,477
*Since 21 August 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar